Gastro-oesophageal reflux disease is associated with up-regulation of desmosomal components in oesophageal mucosa

Histopathology

Volumn 60, Issue 3, 2012, Pages 405-415

  Wex, Thomas ^a   Mönkemüller, Klaus ^a   Stahr, Antje ^a   Kuester, Doerthe ^a   Fry, Lucia C ^a   Völkel, Simone ^a   Kandulski, Arne ^a   Roessner, Albert ^a   Malfertheiner, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Desmogleins; Desmosomes; Gastro oesophageal reflux disease; GERD; Inflammation; Oesophagitis; Oesophagus; Plakoglobin

Indexed keywords

DESMOGLEIN 1; DESMOGLEIN 2; DESMOGLEIN 3; PLAKOGLOBIN;

ADULT; AGED; ARTICLE; BASAL CELL; BASAL CELL HYPERPLASIA; CELL HYPERPLASIA; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DESMOSOME; DISEASE ASSOCIATION; ESOPHAGUS MUCOSA; FEMALE; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTERCELLULAR SPACE; INTERCELLULAR SPACE DILATATION; MALE; NON EROSIVE REFLUX DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REFLUX ESOPHAGITIS; UPREGULATION;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY; DESMOGLEINS; DESMOSOMES; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGITIS; ESOPHAGUS; FEMALE; GAMMA CATENIN; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PROSPECTIVE STUDIES; UP-REGULATION; YOUNG ADULT;

EID: 84856249698     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.04123.x     Document Type: Article

References (53)

1. Fass R. Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J. Clin. Gastroenterol. 2007; 41; 131-137.
2. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am. J. Gastroenterol. 2006; 101; 1900-1920.
3. Boeckxstaens GE. The pathophysiology of gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 2007; 26; 149-160.
4. Dent J. Pathogenesis of gastro-oesophageal reflux disease and novel options for its therapy. Neurogastroenterol. Motil. 2008; 20(Suppl. 1); 91-102.
5. Roberts NB. Human pepsins-their multiplicity, function and role in reflux disease. Aliment. Pharmacol. Ther. 2006; 24(Suppl. 2); 2-9.
6. Sifrim D, Mittal R, Fass R et al. Acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms. Aliment. Pharmacol. Ther. 2007; 25; 1003-1017.
7. Ismail-Beigi F, Horton PF, Pope CE 2nd. Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970; 58; 163-174.
8. Hopwood D, Milne G, Logan KR. Electron microscopic changes in human oesophageal epithelium in oesophagitis. J. Pathol. 1979; 129; 161-167.
9. Tobey NA, Carson JL, Alkiek RA, Orlando RC. Dilated intercellular spaces: a morphological feature of acid reflux-damaged human esophageal epithelium. Gastroenterology 1996; 111; 1200-1205.
10. Odze RD. Unraveling the mystery of the gastroesophageal junction: a pathologist's perspective. Am. J. Gastroenterol. 2005; 100; 1853-1867.
11. Vieth M, Fiocca R, Haringsma J et al. Radial distribution of dilated intercellular spaces of the esophageal squamous epithelium in patients with reflux disease exhibiting discrete endoscopic lesions. Dig. Dis. 2004; 22; 208-212.
12. Vieth M, Peitz U, Labenz J et al. What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett's mucosa? Dig. Dis. 2004; 22; 196-201.
13. Allende DS, Yerian LM. Diagnosing gastroesophageal reflux disease: the pathologist's perspective. Adv. Anat. Pathol. 2009; 16; 161-165.
14. Calabrese C, Fabbri A, Bortolotti M et al. Dilated intercellular spaces as a marker of oesophageal damage: comparative results in gastro-oesophageal reflux disease with or without bile reflux. Aliment. Pharmacol. Ther. 2003; 18; 525-532.
15. Solcia E, Villani L, Luinetti O et al. Altered intercellular glycoconjugates and dilated intercellular spaces of esophageal epithelium in reflux disease. Virchows Arch. 2000; 436; 207-216.
16. Asaoka D, Miwa H, Hirai S et al. Altered localization and expression of tight-junction proteins in a rat model with chronic acid reflux esophagitis. J. Gastroenterol. 2005; 40; 781-790.
17. Miwa H, Oshima T, Sakurai J et al. Experimental oesophagitis in the rat is associated with decreased voluntary movement. Neurogastroenterol. Motil. 2009; 21; 296-303.
18. Li FY, Li Y. Interleukin-6, desmosome and tight junction protein expression levels in reflux esophagitis-affected mucosa. World J. Gastroenterol. 2009; 15; 3621-3630.
19. Jovov B, Van Itallie CM, Shaheen NJ et al. Claudin-18: a dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance. Am. J. Physiol. Gastrointest. Liver Physiol. 2007; 293; G1106-G1113.
20. Garrod D, Chidgey M. Desmosome structure, composition and function. Biochim. Biophys. Acta 2008; 1778; 572-587.
21. Marchiando AM, Graham WV, Turner JR. Epithelial barriers in homeostasis and disease. Annu. Rev. Pathol. 2010; 5; 119-144.
22. Yu QH, Yang Q. Diversity of tight junctions (TJs) between gastrointestinal epithelial cells and their function in maintaining the mucosal barrier. Cell Biol. Int. 2009; 33; 78-82.
23. Turner JR. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 2009; 9; 799-809.
24. Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J. Allergy Clin. Immunol. 2009; 124; 3-20.
25. Scothern A, Garrod D. Visualization of desmosomes in the electron microscope. Methods Cell Biol. 2008; 88; 347-366.
26. McGrath JA, Bolling MC, Jonkman MF. Lethal acantholytic epidermolysis bullosa. Dermatol. Clin. 2010; 28; 131-135.
27. McGrath JA, Mellerio JE. Ectodermal dysplasia-skin fragility syndrome. Dermatol. Clin. 2010; 28; 125-129.
28. Veldman C, Feliciani C. Pemphigus: a complex T cell-dependent autoimmune disorder leading to acantholysis. Clin. Rev. Allergy Immunol. 2008; 34; 313-320.
29. Lai-Cheong JE, Arita K, McGrath JA. Genetic diseases of junctions. J. Invest. Dermatol. 2007; 127; 2713-2725.
30. McGrath JA. Inherited disorders of desmosomes. Australas. J. Dermatol. 2005; 46; 221-229.
31. Mönkemüller K, Wex T, Kuester D et al. Interleukin-1beta and interleukin-8 expression correlate with the histomorphological changes in esophageal mucosa of patients with erosive and non-erosive reflux disease. Digestion 2009; 79; 186-195.
32. Wex T, Mönkemüller K, Kuester D et al. Gastroesophageal reflux disease does not lead to changes in the secretory leukocyte protease inhibitor expression in esophageal mucosa. Eur. J. Gastroenterol. Hepatol. 2009; 21; 150-158.
33. Wex T, Treiber G, Lendeckel U, Malfertheiner P. A two-step method for the extraction of high-quality RNA from endoscopic biopsies. Clin. Chem. Lab. Med. 2003; 41; 1033-1037.
34. Isomoto H, Saenko VA, Kanazawa Y et al. Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease. Am. J. Gastroenterol. 2004; 99; 589-597.
35. Kanazawa Y, Isomoto H, Wen CY et al. Impact of endoscopically minimal involvement on IL-8 mRNA expression in esophageal mucosa of patients with non-erosive reflux disease. World J. Gastroenterol. 2003; 9; 2801-2804.
36. Isomoto H, Wang A, Mizuta Y et al. Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am. J. Gastroenterol. 2003; 98; 551-556.
37. Isomoto H, Kanazawa Y, Nishi Y, Wen CY, Inoue K, Kohno S. Expression of CXC receptor 1 and 2 in esophageal mucosa of patients with reflux esophagitis. World J. Gastroenterol. 2005; 11; 1793-1797.
38. Debruyne PR, Witek M, Gong L et al. Bile acids induce ectopic expression of intestinal guanylyl cyclase C through nuclear factor-kappaB and Cdx2 in human esophageal cells. Gastroenterology 2006; 130; 1191-1206.
39. Kandulski A, Wex T, Mönkemüller K et al. Proteinase activated receptor-2 (PAR-2) in the pathogenesis of gastroesophageal reflux disease. Am. J. Gastroenterol. 2010; 105; 1934-1943.
40. Cheng L, Cao W, Behar J, Fiocchi C, Biancani P, Harnett KM. Acid-induced release of platelet-activating factor by human esophageal mucosa induces inflammatory mediators in circular smooth muscle. J. Pharmacol. Exp. Ther. 2006; 319; 117-126.
41. Tutar E, Ertem D, Unluguzel G et al. Reactive oxygen species and chemokines: are they elevated in the esophageal mucosa of children with gastroesophageal reflux disease? World J. Gastroenterol. 2008; 14; 3218-3223.
42. Inamori M, Shimamura T, Nagase H et al. mRNA expression of inducible nitric oxide synthase, endothelial nitric oxide synthase and vascular endothelial growth factor in esophageal mucosa biopsy specimens from patients with reflux esophagitis. Hepatogastroenterology 2006; 53; 361-365.
43. Yamaguchi T, Yoshida N, Tomatsuri N et al. Cytokine-induced neutrophil accumulation in the pathogenesis of acute reflux esophagitis in rats. Int. J. Mol. Med. 2005; 16; 71-77.
44. Hamaguchi M, Fujiwara Y, Takashima T et al. Increased expression of cytokines and adhesion molecules in rat chronic esophagitis. Digestion 2003; 68; 189-197.
45. Farré R, van Malenstein H, De Vos R et al. Short exposure of oesophageal mucosa to bile acids, both in acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces. Gut 2008; 57; 1366-1374.
46. Tobey NA, Hosseini SS, Argote CM, Dobrucali AM, Awayda MS, Orlando RC. Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am. J. Gastroenterol. 2004; 99; 3-22.
47. Matos RT, Honório RS, Caldini EG, Hashimoto CL, Ferreira MA, Navarro-Rodriguez T. Variation of the intercellular space in the esophageal epithelium in response to hydrochloric acid infusion in patients with erosive esophagitis. Clinics (Sao Paulo) 2009; 64; 669-674.
48. Orlando LA, Orlando RC. Dilated intercellular spaces as a marker of GERD. Curr. Gastroenterol. Rep. 2009; 11; 190-194.
49. Souza RF, Huo X, Mittal V et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology 2009; 137; 1776-1784.
50. Rieder F, Cheng L, Harnett KM et al. Gastroesophageal reflux disease-associated esophagitis induces endogenous cytokine production leading to motor abnormalities. Gastroenterology 2007; 132; 154-165.
51. Mullin JM, Valenzano MC, Trembeth S et al. Transepithelial leak in Barrett's esophagus. Dig. Dis. Sci. 2006; 51; 2326-2336.
52. Gyõrffy H, Holczbauer A, Nagy P et al. Claudin expression in Barrett's esophagus and adenocarcinoma. Virchows Arch. 2005; 447; 961-968.
53. Rendon-Huerta E, Valenzano MC, Mullin JM et al. Comparison of three integral tight junction barrier proteins in Barrett's epithelium versus normal esophageal epithelium. Am. J. Gastroenterol. 2003; 98; 901-903.